Nutraveris
Wednesday, February 28, 2018
Category : NEWS, INGREDIENTS, INNOVATION, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

This study aims to report through a systematic review and meta-analysis the cardiovascular effects of olive oil consumption compared with other plant oils.

 

Olive oil

This systematic review and meta-analysis of randomized controlled trials investigate the effects of olive oil consumption compared with other plant oils on blood lipids. To do so, PubMed, web of science, Scopus, ProQuest, and Embase were searched until September 2017, with no age, language and design restrictions. Weighed mean difference (WMD) and 95% confidence interval (CI) were expressed as effect size. Meta-regression analyses were performed to investigate association between blood lipid-lowering effects of olive oil and duration of treatment.

Twenty-seven trials, comprising 1089 participants met the eligibility criteria.

Results of this study showed that compared to other plant oils, high-density lipoprotein level increased significantly more for olive oil 1.37 mg/dl: 95% CI: 0.4, 2.36). Also olive oil consumption reduced total cholesterol (6.27 mg/dl, 95% CI: 2.8, 10.6), Low-density lipoprotein (4.2 mg/dl, 95% CI: 1.4, 7.01), and triglyceride (4.31 mg/dl, 95% CI: 0.5, 8.12) significantly less than other plant oils. There were no significant effects on Apo lipoprotein A1 and Apo lipoprotein B.

To conclude, this meta-analysis suggested that olive oil consumption decreased serum total cholesterol, LDL-c, and triglycerides less but increased HDL-c more than other plant oils.

 

Ghobadi S, Hassanzadeh-Rostami Z, Mohammadian F, Nikfetrat A, Ghasemifard N, Raeisi Dehkordi H, Faghih S,  Comparison of blood lipid-lowering effects of olive oil and other plant oils: a systematic review and meta-analysis of 27 randomized placebo-controlled clinical trials. Crit Rev Food Sci Nutr. 2018 Feb 8:0.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Wednesday, February 21, 2018
Category : TRAINING | Author : experts | Comment : No Comments
Tags:

From 1st January 2018 Regulation (EU) 2015/2283 on novel foods repeals and replaces previous Regulation (EC) No 258/97.

This new regulation on novel foods particularly clarifies the Novel food definition and simplifies the authorization procedure.

Join our webinar on novel food proposed by our experts, Dr. Thomas Pauquai and Dr. Jérôme Le Bloc’h, PhD experienced with all kind of ingredients (botanicals, substances, minerals, etc…) and successfully won novel food approvals.

 

February  the 27th,  from 2 pm to 2.30 pm

100% FREE

& more than 30 minutes of free information

 

 

 

Thomas Pauquai

Dr. Thomas Pauquai
Head of Health Claim & Food Safety Department

 

Jérôme Le BLOC'H, NUTRAVERIS

Dr. Jérôme Le Bloc’h
Health Claim & Food Safety Department

 

 

 

18c rue du Sabot 22440 Ploufragan, FRANCE
Phone: +33(0)2 96 76 54 87
 contact@nutraveris.com

Tuesday, February 20, 2018
Category : NEWS, INGREDIENTS, INNOVATION, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

This new study, randomized, double-blinded and placebo-controlled trial reinforce this interest of saffron for the management of body weight, by demonstrating an appetite-reducing effect.

saffron

In this study, 84 adults of coronary artery disease have received 30 mg/day saffron, 30 mg/day crocin, a saffron active, or a placebo for 8 weeks. Subjects with overweighed, with a mean BMI around 28.

After 8 weeks of supplementation, the reduction in body was 2.3 kg in the saffron group and 0.89 kg in the crocin group. These effects were statistically different from the placebo group, which did not experienced a reduction in body weight. Moreover, saffron intake was associated with a reduction in BMI, fat mass and fat percentage. These effects were significantly different from placebo.

 

Interestingly, in comparison to placebo, saffron has reduced energy intake (-170.44 kcal/day), has improved the feelings of fullness and satiety, and has reduced the feelings of hunger.

This new study confirm the beneficial effects of saffron on body weight, involving probably an appetite moderation.

 

 

Abedimanesh N, Bathaie SZ, Abedimanesh S, Motlagh B, Separham A, Ostadrahimi A. Saffron and crocin improved appetite, dietary intakes and body composition in patients with coronary artery disease. J Cardiovasc Thorac Res. 2017;9(4):200-208.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, February 15, 2018
Category : NEWS, INGREDIENTS, INNOVATION, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

 NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

The aim of this study was to evaluate the effects of Lactococcus lactis subsp. cremoris FC on intestinal transit in healthy young women. This study was double blinded and placebo-controlled. 31 women have been included, and received either a control non-fermented milk or a fermented milk containing the probiotic for 4 weeks.

Lactococcus lactis subsp. cremoris FC

In comparison to baseline, the probiotic induced an increase in defecation frequency and in stool volume. The effect was also observed in participants with mild constipation. Moreover, in these constipated subjects, stool ammonia concentration was significantly lower in the supplemented group than in the control group.

 

Consequently, these results suggest that Lactococcus lactis subsp. cremoris FC may improve intestinal transit, may therefore be used for the management of constipation.

 

Ozaki K, Maruo T, Kosaka H, Mori M, Mori H, Yamori Y, Toda T. The effects of fermented milk containing Lactococcus lactis subsp. cremoris FC on defaecation in healthy young Japanese women: a double-blind, placebo-controlled study. Int J Food Sci Nutr. 2018 Jan 16:1-8.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Wednesday, February 14, 2018
Category : NEWS, CLAIMS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

 NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

The effects of resveratrol on blood pressure are controversial. Consequently, the authors of this systematic review and meta-analysis was to analyze randomized and controlled trials to clarify the effects of resveratrol on blood pressure. 17 clinical trials have been identified.

 

resveratrol

 

Overall, resveratrol had no significant effect on systolic blood pressure (WMD= -2.5 mHg, 95% CI: -5.5, 0.6 mmHg, p = 0.116), diastolic blood pressure (WMD= -0.5 mmHg, 95% CI: -2.2, 1.3 mmHg, p = 0.613) and mean arterial blood pressure (WMD= -1.3 mmHg,95% CI: -2.8, 0.1 mmHg, p = 0.070).

However, sub-group analysis showed that resveratrol may affect blood pressure for high daily intakes (> 300 mg/day) or in diabetic patients. There was a positive association between the resveratrol lowering effect on systolic blood pressure and BMI at baseline (p = 0.04).

 

In conclusion, resveratrol has no clear effects on blood pressure in the general population, but may have significant hypertensive effects at high dosage (> 300 mg/day) and in diabetic subjects.

 

Fogacci F, Tocci G, Presta V, Fratter A, Borghi C, Cicero AFG. Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr. 2018 Jan 23:1-14.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87